Here’s the press release from the American Association for Clinical Chemistry. “For the first time, Holmes will present data at a scientific conference that describes Theranos’ technologies, including small sample volume testing and finger-stick collection,” the release says.
Theranos spokeswoman Brooke Buchanan confirmed the presentation, saying, “We’re really excited about the opportunity to share our technology with the world.”
Theranos has never presented or published in a scientific journal research that would demonstrate the effectiveness of its proprietary technology, which the company calls “Edison.”
AACC press release:
AACC is pleased to announce that Theranos founder and CEO Elizabeth Holmes will give a plenary presentation at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia. For the first time, Holmes will present data at a scientific conference that describes Theranos’ technologies, including small sample volume testing and finger-stick collection.
After Theranos launched its retail testing service in 2013, it quickly gained national prominence with its promise of revolutionizing the way lab testing works in the United States. The company asserted that its proprietary technologies could perform tests on a capsule-sized blood sample collected from patients via finger-stick. Using these tiny samples, the company promised to improve access and provide results more quickly than traditional lab companies, while charging less.
Holmes will present on Theranos’ technologies on August 1 at the 68th AACC Annual Scientific Meeting, the largest and most recognized international forum for presenting vital science and groundbreaking advances in laboratory medicine. Attendees of the meeting are experts in the field, with the knowledge and experience needed to assess Theranos’ data. After her presentation, Holmes will answer questions from these experts to further clarify the science, accuracy, and reliability of Theranos’ technologies, as well as its impact on patient care and safety.
“There is no better place to present Theranos’ technology than Read More …
Source:: Future of You